Posted by Stacy Sanders on Apr 9th, 2024
Several analysts have recently updated their ratings and price targets for DURECT (NASDAQ: DRRX):
4/1/2024 – DURECT had its “outperform” rating reaffirmed by analysts at Oppenheimer Holdings Inc.. They now have...
More of this article »